高级检索
    评价者: 叶长生, 姚广裕, 文献合成者: 周文琪. 检测循环肿瘤DNA中ESR1突变在晚期乳腺癌治疗中的价值[J]. 循证医学, 2016, 16(3): 143-144. DOI: 10.12019/j.issn.1671-5144.2016.03.006
    引用本文: 评价者: 叶长生, 姚广裕, 文献合成者: 周文琪. 检测循环肿瘤DNA中ESR1突变在晚期乳腺癌治疗中的价值[J]. 循证医学, 2016, 16(3): 143-144. DOI: 10.12019/j.issn.1671-5144.2016.03.006
    shu
    Reviewers: YE Chang-sheng, YAO Guang-yu, Literature Co-worker: ZHOU Wen-qi. Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 143-144. DOI: 10.12019/j.issn.1671-5144.2016.03.006
    Citation: Reviewers: YE Chang-sheng, YAO Guang-yu, Literature Co-worker: ZHOU Wen-qi. Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 143-144. DOI: 10.12019/j.issn.1671-5144.2016.03.006
    shu

    检测循环肿瘤DNA中ESR1突变在晚期乳腺癌治疗中的价值

    Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Advanced Breast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回